Myeloprotection with drug-resistance genes (Q34569911)

3 August 2017

1 reference

title

Myeloprotection with drug-resistance genes (English)

1 reference

3 August 2017

Debabrata Banerjee

1

1 reference

3 August 2017

Joseph R Bertino

series ordinal

2

1 reference

3 August 2017

publication date

1 March 2002

1 reference

Lancet Oncology Commission

3 August 2017

published in

1 reference

3 August 2017

volume

3

1 reference

3 August 2017

issue

3

1 reference

3 August 2017

page(s)

154-158

1 reference

Gene therapy -- promises, problems and prospects

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900678-2

7 January 2021

Gene therapy: trials and tribulations

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900678-2

7 January 2021

Latest developments in gene transfer technology: achievements, perspectives, and controversies over therapeutic applications

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900678-2

7 January 2021

Genetic immunotherapy for cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900678-2

7 January 2021

Cancer gene therapy: hard lessons and new courses

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900678-2

7 January 2021

Gene Replacement Strategies for Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900678-2

7 January 2021

Adenovirus-mediated p14(ARF) gene transfer in human mesothelioma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900678-2

7 January 2021

Chemosensitisation of malignant melanoma by BCL2 antisense therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900678-2

7 January 2021

Antisense oligonucleotides as therapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900678-2

7 January 2021

Attenuated multi–mutated herpes simplex virus–1 for the treatment of malignant gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900678-2

7 January 2021

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900678-2

7 January 2021

A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900678-2

7 January 2021

Dendritic cell vaccines for cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900678-2

7 January 2021

Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900678-2

7 January 2021

Genetic vaccination: the advantages of going naked

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900678-2

7 January 2021

DNA vaccines--designer vaccines for the 21st century

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900678-2

7 January 2021

"Turning the tables"--making normal marrow resistant to chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900678-2

7 January 2021

Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900678-2

7 January 2021

5-year results of dose-intensive sequential adjuvant chemotherapy for women with high-risk node-positive breast cancer: A phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900678-2

7 January 2021

Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900678-2

7 January 2021

The cHS4 insulator increases the probability of retroviral expression at random chromosomal integration sites.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900678-2

7 January 2021

Design of 5' untranslated sequences in retroviral vectors developed for medical use.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900678-2

7 January 2021

In vivo selection of retrovirally transduced hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900678-2

7 January 2021

Isolation and characterization of thymitaq (AG337) and 5-fluoro-2-deoxyuridylate-resistant mutants of human thymidylate synthase from ethyl methanesulfonate-exposed human sarcoma HT1080 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900678-2

7 January 2021

Random sequence mutagenesis and resistance to 5-fluorouridine in human thymidylate synthases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900678-2

7 January 2021

Expression of a novel double-mutant dihydrofolate reductase-cytidine deaminase fusion gene confers resistance to both methotrexate and cytosine arabinoside

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900678-2

7 January 2021

Efficient retrovirus-mediated transfer of the multidrug resistance 1 gene into autologous human long-term repopulating hematopoietic stem cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900678-2

7 January 2021

Phase I trial of retroviral-mediated transfer of the human MDR1 gene as marrow chemoprotection in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900678-2

7 January 2021

Glutathione S-transferases: gene structure and regulation of expression

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900678-2

7 January 2021

Retrovirus-mediated gene transfer of rat glutathione S-transferase Yc confers in vitro resistance to alkylating agents in human leukemia cells and in clonogenic mouse hematopoietic progenitor cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900678-2

7 January 2021

Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900678-2

7 January 2021

Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900678-2

7 January 2021

A novel dual function retrovirus expressing multidrug resistance 1 and O6-alkylguanine-DNA-alkyltransferase for engineering resistance of haemopoietic progenitor cells to multiple chemotherapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900678-2

7 January 2021

Gene therapy utilizing drug resistance genes: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900678-2

7 January 2021

In vivo drug-selectable genes: a new concept in gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900678-2

7 January 2021

10.1016/S1470-2045(02)00678-2

Identifiers

DOI

1 reference

3 August 2017

1 reference